Octaware Technologies has appointed Divya Mittal as an additional director in the category of non-executive independent director. The Board of Directors approved the appointment on August 17, 2026, based on the recommendation of the Nomination and Remuneration Committee.

The appointment takes effect on August 20, 2026, for a first term of five consecutive years, concluding on August 19, 2031. This tenure is subject to the approval of the company’s shareholders. Ms Mittal is not liable to retire by rotation.

Regulatory Compliance and Independence

In compliance with Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Octaware confirmed that Ms Mittal meets the criteria of independence under the Companies Act, 2013 and SEBI LODR Regulations. She has provided requisite declarations confirming she is not debarred from holding office by SEBI or any other authority and is not disqualified under Section 164 of the Companies Act, 2013.

Profile of Appointee

Divya Mittal (DIN: 11902340) holds an MBA in Marketing, a B.Sc. in Biology, and a B.Ed. She possesses more than 20 years of experience primarily within pharmaceutical and healthcare companies.

Her professional background includes:

• Current role managing HR, sales, and marketing at Dr. Fresh Assets Ltd.
• Previous tenures with Pfizer India, Cipla, and Innovex India in roles focused on sales, marketing, team management, and training.
• Training experience with Aventis Pharma and HCL Infosys.

Ms Mittal disclosed no relationships with existing directors and holds no committee memberships or chairmanships at this stage.

Octaware Technologies Limited announced that its board of directors has approved the proposed shifting of the company's registered office from the state of Maharashtra to the state of Uttar Pradesh. The decision was taken at a board meeting held on August 20, 2026.

The proposal is subject to the approval of members and further confirmation from the Central Government. The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance

The company notified BSE Limited of the development under Regulation 30 and Regulation 33 of the SEBI LODR Regulations. The board meeting concluded at 4:30 pm. Mohammed Aslam Quadratullah Khan, Managing Director, signed the communication on behalf of the company.